BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weyand CM, Watanabe R, Zhang H, Akiyama M, Berry GJ, Goronzy JJ. Cytokines, growth factors and proteases in medium and large vessel vasculitis. Clin Immunol 2019;206:33-41. [PMID: 30772599 DOI: 10.1016/j.clim.2019.02.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Higashida-Konishi M, Akiyama M, Shimada T, Hama S, Oshige T, Izumi K, Oshima H, Okano Y. Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy. Rheumatol Int 2022. [PMID: 36152056 DOI: 10.1007/s00296-022-05217-x] [Reference Citation Analysis]
2 Stock AT, Parsons S, Sharma VJ, James F, Starkey G, D'Costa R, Gordon CL, Wicks IP. Intimal macrophages develop from circulating monocytes during vasculitis. Clin Transl Immunology 2022;11:e1412. [PMID: 35991774 DOI: 10.1002/cti2.1412] [Reference Citation Analysis]
3 Watanabe R, Hashimoto M. Pathogenic role of monocytes/macrophages in large vessel vasculitis. Front Immunol 2022;13:859502. [DOI: 10.3389/fimmu.2022.859502] [Reference Citation Analysis]
4 Watanabe R, Hashimoto M. Vasculitogenic T Cells in Large Vessel Vasculitis. Front Immunol 2022;13:923582. [DOI: 10.3389/fimmu.2022.923582] [Reference Citation Analysis]
5 Wang J, Dai X, Ma L, Wu S, Jin X, Ji Z, Chen H, Ma L, Ding Z, Jiang L, Kong X. Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study. Semin Arthritis Rheum 2022;55:152018. [PMID: 35523066 DOI: 10.1016/j.semarthrit.2022.152018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Watanabe R, Hashimoto M. Perspectives of JAK Inhibitors for Large Vessel Vasculitis. Front Immunol 2022;13:881705. [PMID: 35432355 DOI: 10.3389/fimmu.2022.881705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Watanabe R, Hashimoto M. Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders. Front Aging Neurosci 2022;14:843305. [DOI: 10.3389/fnagi.2022.843305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Costa B, Vale N. Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer. Int J Mol Sci 2022;23:3181. [PMID: 35328602 DOI: 10.3390/ijms23063181] [Reference Citation Analysis]
9 Esen I, Jiemy WF, van Sleen Y, van der Geest KSM, Sandovici M, Heeringa P, Boots AMH, Brouwer E. Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment. J Clin Med 2021;10:4958. [PMID: 34768479 DOI: 10.3390/jcm10214958] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Li HY, Xu JN, Shuai ZW. Cellular signaling pathways of T cells in giant cell arteritis. J Geriatr Cardiol 2021;18:768-78. [PMID: 34659383 DOI: 10.11909/j.issn.1671-5411.2021.09.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Torp CK, Brüner M, Keller KK, Brouwer E, Hauge EM, McGonagle D, Kragstrup TW. Vasculitis therapy refines vasculitis mechanistic classification. Autoimmun Rev 2021;20:102829. [PMID: 33872767 DOI: 10.1016/j.autrev.2021.102829] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
12 Chen F, Li Y, Zhou H, Sun C, Li S, Wang L, Li X, Liu X. Analysis of Development Mechanism of Giant Cell Arteritis in Nude Mouse Model through Color Duplex Sonography and Computerized Tomography Nanocontrast Agent. Biomed Res Int 2021;2021:6627925. [PMID: 33928153 DOI: 10.1155/2021/6627925] [Reference Citation Analysis]
13 Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Innate and Adaptive Immunity in Giant Cell Arteritis. Front Immunol 2020;11:621098. [PMID: 33717054 DOI: 10.3389/fimmu.2020.621098] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
14 Akiyama M. Recognition of Rare, Atypical Manifestations Is Important for Diagnosis and Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Delaval et al. Arthritis Rheumatol 2021;73:719. [PMID: 33191641 DOI: 10.1002/art.41590] [Reference Citation Analysis]
15 Jung JH, Jeong HS, Choi SJ, Song GG, Kim JH, Lee TH, Han Y. Associations between interleukin 18 gene polymorphisms and susceptibility to vasculitis: A meta-analysis. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:203-11. [PMID: 33093784 DOI: 10.36141/svdld.v37i2.9399] [Reference Citation Analysis]
16 Wang L, Ai Z, Khoyratty T, Zec K, Eames HL, van Grinsven E, Hudak A, Morris S, Ahern D, Monaco C, Eruslanov EB, Luqmani R, Udalova IA. ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies. JCI Insight 2020;5:139163. [PMID: 32960815 DOI: 10.1172/jci.insight.139163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
17 Deshayes S, de Boysson H, Dumont A, Vivien D, Manrique A, Aouba A. An overview of the perspectives on experimental models and new therapeutic targets in giant cell arteritis. Autoimmunity Reviews 2020;19:102636. [DOI: 10.1016/j.autrev.2020.102636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Cellular Signaling Pathways in Medium and Large Vessel Vasculitis. Front Immunol 2020;11:587089. [PMID: 33072134 DOI: 10.3389/fimmu.2020.587089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
19 Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences. Curr Rheumatol Rep 2020;22:68. [PMID: 32845392 DOI: 10.1007/s11926-020-00948-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
20 Mears KA, Feinsilber D. High-Sensitivity C-Reactive Protein and Magnetic Resonance Imaging in Occult Giant Cell Arteritis. Cureus 2020;12:e9530. [PMID: 32775116 DOI: 10.7759/cureus.9530] [Reference Citation Analysis]
21 Régnier P, Le Joncour A, Maciejewski-Duval A, Desbois AC, Comarmond C, Rosenzwajg M, Klatzmann D, Cacoub P, Saadoun D. Targeting JAK/STAT pathway in Takayasu's arteritis. Ann Rheum Dis 2020;79:951-9. [PMID: 32213496 DOI: 10.1136/annrheumdis-2019-216900] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
22 Zhang J, Zhao L, Wang J, Cheng Z, Sun M, Zhao J, Liu B, Liu X, Wen Z, Li Z. Targeting Mechanistic Target of Rapamycin Complex 1 Restricts Proinflammatory T Cell Differentiation and Ameliorates Takayasu Arteritis. Arthritis Rheumatol 2020;72:303-15. [DOI: 10.1002/art.41084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
23 Saito S, Okuyama A, Okada Y, Shibata A, Sakai R, Kurasawa T, Kondo T, Takei H, Amano K. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study. Rheumatology 2020;59:1617-21. [DOI: 10.1093/rheumatology/kez511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Watanabe R. Challenging therapeutic goal in large vessel vasculitis: Comment on "Statins reduce relapse rate in Takayasu arteritis" published in the journal. Int J Cardiol 2019;287:120. [PMID: 31079811 DOI: 10.1016/j.ijcard.2019.04.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Kyttaris VC. Targeting cytokines to treat autoimmunity. Clin Immunol 2019;206:108251. [PMID: 31445171 DOI: 10.1016/j.clim.2019.108251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
26 Zaldivar Villon MLF, de la Rocha JAL, Espinoza LR. Takayasu Arteritis: Recent Developments. Curr Rheumatol Rep 2019;21. [DOI: 10.1007/s11926-019-0848-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
27 Akiyama M, Kaneko Y, Takeuchi T. Characteristics and prognosis of IgG4-related periaortitis/periarteritis: A systematic literature review. Autoimmun Rev 2019;18:102354. [PMID: 31323364 DOI: 10.1016/j.autrev.2019.102354] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]